Toluene-2,6-diisocyanate

Toluene diisocyanates (TDI), comprising both the 2,4 and 2,6 isomers, were developed in the 1940s by Otto Bayer and colleagues at I.G. Farben as key raw materials for polyurethane synthesis. [1] Polyurethanes, formed by the reaction of diisocyanates with polyols, became one of the most versatile polymer families of the 20th century — forming the flexible foams in furniture cushions, mattresses, and car seats; rigid insulation panels; adhesives; coatings; and elastomers. Commercial TDI is typically a mixture of approximately 80% 2,4-TDI and 20% 2,6-TDI (abbreviated 80:20 TDI). The 2,6 isomer is less reactive than its 2,4 counterpart due to steric hindrance from the ortho methyl group, but it shares the same toxic properties. [2] TDI became notorious in occupational medicine during the 1950s–1970s for causing epidemic outbreaks of occupational asthma in polyurethane foam factories — workers who developed sensitization experienced severe asthmatic attacks triggered by even tiny subsequent exposures, far below the odor threshold. The mechanism is immunologically complex: TDI haptens to human proteins, creating neoantigens that trigger IgE and T-cell mediated hypersensitivity. [3] OSHA established a permissible exposure limit (PEL) of 0.02 ppm ceiling for all TDI isomers. Modern foam plants use enclosed automated systems to reduce exposure, but isocyanate asthma remains one of the leading causes of occupational asthma worldwide.

Workers in polyurethane foam manufacturing, spray foam insulation installation, polyurethane coating application, and auto body repair are most exposed. Spray foam insulation applicators face some of the highest exposures because the spray generates isocyanate aerosols in the breathing zone. Heating or cutting polyurethane foam can regenerate TDI vapors from thermal degradation. Consumers can be briefly exposed to off-gassing from new foam products, but levels are generally very low.

The defining hazard of TDI is respiratory sensitization: once sensitized — which can occur from even a single acute overexposure or from chronic low-level exposure — affected individuals develop occupational asthma that can be triggered by any subsequent TDI exposure, including concentrations far below the PEL. This sensitization is irreversible. The only treatment is permanent removal from isocyanate exposure. [3] TDI is also irritating to eyes, skin, and mucous membranes, and may cause dermal sensitization. Animal data support carcinogenicity of TDI vapors; the NTP found evidence of respiratory tract tumors.

Polyurethane foam workers, spray foam insulation applicators, auto refinishing workers (polyurethane clear coat sprayers), construction workers installing polyurethane sealants, and firefighters responding to burning polyurethane materials face the highest risks. Atopic individuals (those with pre-existing allergies) may sensitize more readily.

1. Engineering controls are the first priority — fully enclosed mixing and pouring equipment, continuous local exhaust ventilation, and substitution to water-blown or less hazardous blowing agents where possible. 2. When engineering controls cannot reduce exposure below the ceiling, wear supplied-air respirators (not just filtering facepieces) for isocyanate spraying operations. 3. Any worker developing cough, chest tightness, or breathing difficulty during or after TDI work should be removed from exposure immediately and evaluated by an occupational physician. 4. Pre-employment and periodic spirometry and isocyanate-specific IgE testing helps detect early sensitization. 5. Spray foam installers must follow EPA's worker protection requirements for TDI-based products.